Patents by Inventor Beate Illek

Beate Illek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8138158
    Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: March 20, 2012
    Assignee: Children's Hospital & Research Center at Oakland
    Inventors: Horst Fischer, Beate Illek
  • Publication number: 20100286256
    Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.
    Type: Application
    Filed: March 11, 2010
    Publication date: November 11, 2010
    Inventors: Horst Fischer, Beate Illek
  • Patent number: 7718694
    Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: May 18, 2010
    Assignee: Children's Hospital & Research Center at Oakland
    Inventors: Horst Fischer, Beate Illek
  • Patent number: 7335683
    Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.
    Type: Grant
    Filed: October 17, 2001
    Date of Patent: February 26, 2008
    Assignee: Children's Hospital & Research Center at Oakland
    Inventors: Horst Fischer, Beate Illek
  • Publication number: 20040197272
    Abstract: Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport.
    Type: Application
    Filed: January 30, 2004
    Publication date: October 7, 2004
    Applicant: Children's Hospital Oakland
    Inventors: Horst Fischer, Beate Illek
  • Publication number: 20030096762
    Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.
    Type: Application
    Filed: October 17, 2001
    Publication date: May 22, 2003
    Applicant: Children's Hospital Oakland
    Inventors: Horst Fischer, Beate Illek
  • Patent number: 6329422
    Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: December 11, 2001
    Assignee: Children's Hospital Oakland Research Institute
    Inventors: Horst Fischer, Beate Illek
  • Patent number: 5972995
    Abstract: Compositions and methods for therapy of cystic fibrosis and other conditions are provided. The compositions comprise one or more flavones and/or isoflavones capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of chloride transport.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: October 26, 1999
    Assignee: Children's Hospital Medical Center of Northern California
    Inventors: Horst Bernhard Fischer, Beate Illek